dexmedetomidine has been researched along with Adenocarcinoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, XJ; Cao, FJ; Li, D; Liu, S; Song, Y; Yu, XJ; Zhang, L; Zhang, W; Zuo, ZG | 1 |
| Ben-Eliyahu, S; Benbenishty, A; Cata, JP; Elbaz, E; Gottumukkala, V; Haldar, R; Lavon, H; Matzner, P; Rossene, E; Sorski, L | 1 |
| Brown, EB; Burke, KA; Dawes, RP; Madden, KS; Szpunar, MJ | 1 |
| Fujinaga, Y; Kashiwa, A; Kojima, Y; Matsuyama, K; Shimamoto, F; Takimoto, K; Toyonaga, T; Ueda, T; Yamauchi, H; Yoshikawa, T | 1 |
1 trial(s) available for dexmedetomidine and Adenocarcinoma
| Article | Year |
|---|---|
Sedation with dexmedetomidine hydrochloride during endoscopic submucosal dissection of gastric cancer.
Topics: Adenocarcinoma; Adenoma; Aged; Aged, 80 and over; Arousal; Conscious Sedation; Dexmedetomidine; Dissection; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gastric Mucosa; Gastroscopy; Humans; Hypnotics and Sedatives; Infusions, Intravenous; Male; Midazolam; Middle Aged; Neoplasm Staging; Propofol; Prospective Studies; Stomach Neoplasms | 2011 |
3 other study(ies) available for dexmedetomidine and Adenocarcinoma
| Article | Year |
|---|---|
Dexmedetomidine inhibits the growth and metastasis of esophageal cancer cells by down-regulation of lncRNA MALAT1.
Topics: Adenocarcinoma; Animals; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dexmedetomidine; Down-Regulation; Esophageal Neoplasms; Ki-67 Antigen; Mice; MicroRNAs; RNA, Long Noncoding | 2022 |
Dexmedetomidine promotes metastasis in rodent models of breast, lung, and colon cancers.
Topics: Adenocarcinoma; Adrenergic alpha-2 Receptor Agonists; Animals; Carcinoma, Lewis Lung; Colonic Neoplasms; Dexmedetomidine; Female; Hypnotics and Sedatives; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms, Experimental; Rats; Rats, Inbred F344; Receptors, Adrenergic, alpha-2 | 2018 |
The antidepressant desipramine and α2-adrenergic receptor activation promote breast tumor progression in association with altered collagen structure.
Topics: Adenocarcinoma; Adrenergic alpha-2 Receptor Agonists; Animals; Antidepressive Agents, Tricyclic; Apoptosis; Breast Neoplasms; Cell Proliferation; Collagen; Cytokines; Desipramine; Dexmedetomidine; Disease Progression; Female; Humans; Image Processing, Computer-Assisted; Immunoenzyme Techniques; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Fluorescence, Multiphoton; Norepinephrine; Receptors, Adrenergic, alpha-2; Tumor Cells, Cultured | 2013 |